Novel HLA-B alleles identified in potential marrow donors: B*3917, B*1405 and B*3528.

Tissue Antigens

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19035, USA.

Published: September 2001

Sequence-specific oligonucleotide probe hybridization and sequence-specific primer polymerase chain reaction (PCR) typing of volunteer bone marrow donors suggested the presence of variants of known HLA-B alleles in five individuals. PCR products encompassing HLA-B locus exons 1 through 3 were prepared and subcloned. Three African-American individuals had a novel HLA-B*39 allele (B*3917), and another African-American was found to have a novel HLA-B*14 allele (B*1405). In a third individual of Hispanic origin, a novel HLA-B*35 allele (B*3528) was identified. These findings further illustrate the substantial genetic variation present at the HLA-B locus within human populations.

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1399-0039.2001.580312.xDOI Listing

Publication Analysis

Top Keywords

hla-b alleles
8
marrow donors
8
hla-b locus
8
novel
4
novel hla-b
4
alleles identified
4
identified potential
4
potential marrow
4
donors b*3917
4
b*3917 b*1405
4

Similar Publications

Novel Allele HLA-B*52:130, Identified by Next-Generation Sequencing.

HLA

January 2025

Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, Moscow, Russia.

The new HLA-B*52:130 allele showed one nonsynonymous nucleotide difference compared to the HLA-B*52:01:01:01 allele in codon 170.

View Article and Find Full Text PDF

The novel allele HLA-HLA-B*40:02:39 differs from HLA-B*40:02:01:01 by one synonymous nucleotide substitution in exon 2.

View Article and Find Full Text PDF

HLA-B*38:122 differs from HLA-B*38:01:01:01 by eight nucleotides substutions in Exon 3.

View Article and Find Full Text PDF

The HLA-B*40:01:82 allele differs from HLA-B:40:01:01 by a single synonymous nucleotide in exon 4.

View Article and Find Full Text PDF

Molecular docking to investigate HLA-associated idiosyncratic drug reactions.

Drug Metab Rev

January 2025

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Idiosyncratic drug reactions (IDRs) pose severe threats to patient health. Unlike conventionally dose-dependent side effects, they are unpredictable and frequently manifest as life-threatening conditions, such as severe cutaneous adverse reactions (SCARs) and drug-induced liver injury (DILI). Some HLA alleles, such as , , and , are known risk factors for adverse reactions induced by multiple drugs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!